Royal Bank of Canada’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-5,074
| Closed | -$262K | – | 8176 |
|
|
2022
Q3 | $262K | Buy |
5,074
+2,236
| +79% | +$92.4K | ﹤0.01% | 4535 |
|
|
2022
Q2 | $70K | Sell |
2,838
-2,577
| -48% | -$56.8K | ﹤0.01% | 5553 |
|
|
2022
Q1 | $136K | Sell |
5,415
-5,967
| -52% | -$168K | ﹤0.01% | 5417 |
|
|
2021
Q4 | $414K | Buy |
11,382
+1,961
| +21% | +$68.8K | ﹤0.01% | 4642 |
|
|
2021
Q3 | $161K | Buy |
9,421
+627
| +7% | +$9.77K | ﹤0.01% | 5356 |
|
|
2021
Q2 | $118K | Buy |
8,794
+6,528
| +288% | +$161K | ﹤0.01% | 5501 |
|
|
2021
Q1 | $116K | Buy |
2,266
+2,009
| +782% | +$121K | ﹤0.01% | 5357 |
|
|
2020
Q4 | $16K | Hold |
257
| – | – | ﹤0.01% | 6176 |
|
|
2020
Q3 | $14K | Sell |
257
-2,061
| -89% | -$111K | ﹤0.01% | 5831 |
|
|
2020
Q2 | $134K | Buy |
2,318
+1,929
| +496% | +$105K | ﹤0.01% | 4681 |
|
|
2020
Q1 | $16K | Buy |
389
+353
| +981% | +$15K | ﹤0.01% | 5652 |
|
|
2019
Q4 | $1K | Buy |
+36
| New | +$632 | ﹤0.01% | 6730 |
|
|
2018
Q4 | – | Sell |
-277
| Closed | -$4K | – | 7297 |
|
|
2018
Q3 | $4K | Buy |
277
+265
| +2,208% | +$3.19K | ﹤0.01% | 6367 |
|
|
2018
Q2 | $0 | Buy |
12
+9
| +300% | +$108 | ﹤0.01% | 6882 |
|
|
2018
Q1 | $0 | Sell |
3
-154
| -98% | -$1.59K | ﹤0.01% | 6966 |
|
|
2017
Q4 | $1K | Sell |
157
-1,975
| -93% | -$13.5K | ﹤0.01% | 6450 |
|
|
2017
Q3 | $16K | Buy |
+2,132
| New | +$17.7K | ﹤0.01% | 6081 |
|
|
2017
Q2 | – | Sell |
-605
| Closed | -$4K | – | 6872 |
|
|
2017
Q1 | $4K | Buy |
605
+355
| +142% | +$2.56K | ﹤0.01% | 6306 |
|
|
2016
Q4 | $2K | Buy |
+250
| New | +$1.8K | ﹤0.01% | 6500 |
|
|
2016
Q1 | – | Sell |
-35
| Closed | – | – | 6758 |
|
|
2015
Q4 | $0 | Sell |
35
-1,313
| -97% | -$9.29K | ﹤0.01% | 6898 |
|
|
2015
Q3 | $8K | Sell |
1,348
-310
| -19% | -$2.24K | ﹤0.01% | 6002 |
|
|
2015
Q2 | $14K | Buy |
1,658
+1,653
| +33,060% | +$13.1K | ﹤0.01% | 5907 |
|
|
2015
Q1 | $0 | Buy |
+5
| New | +$39 | ﹤0.01% | 6488 |
|
Other funds holding CCXI
Royal Bank of Canada's CCXI Position: Q4 2022 in Review
Royal Bank of Canada sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 5,074 shares — an estimated $262K sold.
Royal Bank of Canada first reported a position in CCXI in Q1 2015 and held it in 23 quarters. The position peaked at $414K in Q4 2021. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.
- Royal Bank of Canada reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
- Royal Bank of Canada sold 5,074 ChemoCentryx, Inc. shares in Q4 2022, an estimated $262K.
- Royal Bank of Canada first reported a position in ChemoCentryx, Inc. in Q1 2015 and held it in 23 quarters.
- Royal Bank of Canada's ChemoCentryx, Inc. position peaked at $414K in Q4 2021.
- 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.
Based on Royal Bank of Canada's 13F filing for Q4 2022, filed 14 Feb 2023.